Ballantyne Charles Evan Insider Trades

Insider Trading History

Track insider trading activity for Ballantyne Charles Evan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Gain Therapeutics
Gain Therapeutics GANX
Chief Financial Officer
Holding Value $186k 100,000 shares
Last Trade
Apr 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$479k 100,000 shares
$4.79
$1.86
Agenus
Agenus AGEN
CFO
Holding Value $255k 75,000 shares
Last Trade
Jun 14, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$348k 89,000 shares
$3.91
$3.40
Agenus
Agenus AGEN
Chief Financial Officer
Holding Value $49.7k 14,648 shares
Last Trade
Apr 26, 2016 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$29.2k 7,035 shares
$4.15
$3.40
Agenus
Agenus AGEN
Chief Financial Officer
Holding Value $84.2k 24,795 shares
Last Trade
Apr 26, 2016 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$29.5k 7,107 shares
$4.15
$3.40
Agenus
Agenus AGEN
Chief Financial Officer
Holding Value $73.6k 21,683 shares
Last Trade
Apr 26, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90k 21,683 shares
$4.15
$3.40
Agenus
Agenus AGEN
Chief Financial Officer
Holding Value $108k 31,902 shares
Last Trade
Apr 26, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90.9k 21,902 shares
$4.15
$3.40
Agenus
Agenus AGEN
Chief Financial Officer
Holding Value $34k 10,000 shares
Last Trade
Sep 25, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$50.5k 10,000 shares
$5.05
$3.40
Agenus
Agenus AGEN
Chief Financial Officer
Holding Value $509k 150,000 shares
Last Trade
Jun 17, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.47M 150,000 shares
$9.78
$3.40
Theriva Biologics
Theriva Biologics SYN
Chief Financial Officer
Holding Value $204k 200,000 shares
Last Trade
Jan 08, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$108M 200,000 shares
$539.00
$1.02
Theriva Biologics
Theriva Biologics SYN
Chief Financial Officer
Holding Value $10.2k 10,000 shares
Last Trade
May 22, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.8M 10,000 shares
$479.50
$1.02
Theriva Biologics
Theriva Biologics SYN
Chief Financial Officer
Holding Value $153k 150,000 shares
Last Trade
Apr 17, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132M 150,000 shares
$882.00
$1.02
Theriva Biologics
Theriva Biologics SYN
CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Feb 06, 2012 Sale
$1.05M 425,000 shares
$2.47
$1.02

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up